Seattle Children’s Begins Recruiting Patients for Immunotherapy Research Trial for Neuroblastoma, On

Seattle Children’s today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, one of the deadliest forms of childhood cancer.

Read more here: http://www.newswise.com/articles/seattle-children-s-begins-recruiting-patients-for-immunotherapy-research-trial-for-neuroblastoma-one-of-the-deadliest-forms-of-childhood-cancer?ret=/articles/list&category=medicine&page=1&search[status]=3&search[sort]=date+desc&search[section]=10&search[has_multimedia]=